These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24575659)

  • 1. [Formulation of multiparticular drug delivery systems by compressing pellets into tablets].
    Csobán Z; Kállai N; Polgár A; Antal I
    Acta Pharm Hung; 2013; 83(4):134-42. PubMed ID: 24575659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
    Bendas ER; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hot tableting as a new method for obtaining tablets from slow release-coated pellets.
    Sawicki W; Mazgalski J
    Drug Dev Ind Pharm; 2009 Jul; 35(7):857-65. PubMed ID: 19466897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanical properties of excipients do not affect polymer matrix formation.
    Chatterjee L; Rades T; Tucker IG
    Int J Pharm; 2010 Jan; 384(1-2):87-92. PubMed ID: 19819317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery system.
    Cappello B; De Rosa G; Giannini L; La Rotonda MI; Mensitieri G; Miro A; Quaglia F; Russo R
    Int J Pharm; 2006 Aug; 319(1-2):63-70. PubMed ID: 16650700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of core size and excipients on the lag time and drug release from a pulsatile drug delivery system.
    Efentakis M; Iliopoyloy A; Siamidi A
    Drug Dev Ind Pharm; 2011 Jan; 37(1):113-20. PubMed ID: 20615155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of bilayer tablet technology.
    Abebe A; Akseli I; Sprockel O; Kottala N; Cuitiño AM
    Int J Pharm; 2014 Jan; 461(1-2):549-58. PubMed ID: 24370841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Evaluation of Pellet Cushioning Agents by Various Imaging Techniques and Dissolution Studies.
    Sántha K; Kállai-Szabó N; Fülöp V; Jakab G; Gordon P; Kállai-Szabó B; Balogh E; Antal I
    AAPS PharmSciTech; 2020 Dec; 22(1):14. PubMed ID: 33377174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tableting and tablet properties of alginates: characterisation and potential for Soft Tableting.
    Schmid W; Picker-Freyer KM
    Eur J Pharm Biopharm; 2009 May; 72(1):165-72. PubMed ID: 18992337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multispectral UV imaging for surface analysis of MUPS tablets with special focus on the pellet distribution.
    Novikova A; Carstensen JM; Rades T; Leopold PDCS
    Int J Pharm; 2016 Dec; 515(1-2):374-383. PubMed ID: 27702695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of multiparticulate systems as lyophilised orally disintegrating tablets.
    Alhusban F; Perrie Y; Mohammed AR
    Eur J Pharm Biopharm; 2011 Nov; 79(3):627-34. PubMed ID: 21693189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a multiple-unit tablet containing enteric-coated pellets.
    Dreu R; Ilić I; Srčič S
    Pharm Dev Technol; 2011 Apr; 16(2):118-26. PubMed ID: 20088675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and evaluation of multiple tablets as a biphasic gastroretentive floating drug delivery system for fenoverine.
    Bandari S; Eaga CM; Thadishetty A; Yamsani MR
    Acta Pharm; 2010 Mar; 60(1):89-97. PubMed ID: 20228043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-proccessed excipients with enhanced direct compression functionality for improved tableting performance.
    Rojas J; Buckner I; Kumar V
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1159-70. PubMed ID: 22966909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of formulation variables influencing the drug release rate from matrix tablets by experimental design.
    Furlanetto S; Cirri M; Maestrelli F; Corti G; Mura P
    Eur J Pharm Biopharm; 2006 Jan; 62(1):77-84. PubMed ID: 16154333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of the SeDeM Diagram expert system to determine the suitability of diluents-disintegrants for direct compression and their use in formulation of ODT.
    Aguilar-Díaz JE; García-Montoya E; Pérez-Lozano P; Suñe-Negre JM; Miñarro M; Ticó JR
    Eur J Pharm Biopharm; 2009 Nov; 73(3):414-23. PubMed ID: 19602435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of drug release from compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN).
    Ivic B; Ibric S; Betz G; Zorica D
    Arch Pharm Res; 2010 Jan; 33(1):103-13. PubMed ID: 20191351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets.
    Pund S; Joshi A; Vasu K; Nivsarkar M; Shishoo C
    Int J Pharm; 2010 Mar; 388(1-2):64-72. PubMed ID: 20035851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D.
    Sawicki W; Lunio R
    Eur J Pharm Biopharm; 2005 May; 60(1):153-8. PubMed ID: 15848067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.